These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 22692798)

  • 1. A functionally selective synthetic mimic of the HIV-1 co-receptor CXCR4.
    Möbius K; Dürr R; Haussner C; Dietrich U; Eichler J
    Chemistry; 2012 Jul; 18(27):8292-5. PubMed ID: 22692798
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence as a HIV-1 self-defense vaccine of cyclic chimeric dodecapeptide warped from undecapeptidyl arch of extracellular loop 2 in both CCR5 and CXCR4.
    Misumi S; Takamune N; Ido Y; Hayashi S; Endo M; Mukai R; Tachibana K; Umeda M; Shoji S
    Biochem Biophys Res Commun; 2001 Aug; 285(5):1309-16. PubMed ID: 11478800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis.
    Yao Q; Compans RW; Chen C
    Virology; 2001 Jun; 285(1):128-37. PubMed ID: 11414813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the CD4 receptor versus HIV coreceptors in envelope-mediated apoptosis in peripheral blood mononuclear cells.
    Arthos J; Cicala C; Selig SM; White AA; Ravindranath HM; Van Ryk D; Steenbeke TD; Machado E; Khazanie P; Hanback MS; Hanback DB; Rabin RL; Fauci AS
    Virology; 2002 Jan; 292(1):98-106. PubMed ID: 11878912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthetic heparan sulfate-mimetic peptide conjugated to a mini CD4 displays very high anti- HIV-1 activity independently of coreceptor usage.
    Connell BJ; Baleux F; Coic YM; Clayette P; Bonnaffé D; Lortat-Jacob H
    Chem Biol; 2012 Jan; 19(1):131-9. PubMed ID: 22284360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plugging gp120s cavity.
    Repik A; Clapham PR
    Structure; 2008 Nov; 16(11):1603-4. PubMed ID: 19000812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clarifying the role of G protein signaling in HIV infection: new approaches to an old question.
    Juno JA; Fowke KR
    AIDS Rev; 2010; 12(3):164-76. PubMed ID: 20842205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide, peptidomimetic and small-molecule drug discovery targeting HIV-1 host-cell attachment and entry through gp120, gp41, CCR5 and CXCR4.
    Kazmierski WM; Kenakin TP; Gudmundsson KS
    Chem Biol Drug Des; 2006 Jan; 67(1):13-26. PubMed ID: 16492145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mechanism of resistance to HIV-1 entry: inefficient interactions of CXCR4 with CD4 and gp120 in macrophages.
    Dimitrov DS; Norwood D; Stantchev TS; Feng Y; Xiao X; Broder CC
    Virology; 1999 Jun; 259(1):1-6. PubMed ID: 10364484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication.
    Casoli C; Pilotti E; Perno CF; Balestra E; Polverini E; Cassone A; Conti S; Magliani W; Polonelli L
    AIDS; 2006 Apr; 20(7):975-80. PubMed ID: 16603848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
    Xiao X; Kinter A; Broder CC; Dimitrov DS
    Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
    Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
    J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR4-using viruses in plasma and peripheral blood mononuclear cells during primary HIV-1 infection and impact on disease progression.
    Raymond S; Delobel P; Mavigner M; Cazabat M; Encinas S; Souyris C; Bruel P; Sandres-Sauné K; Marchou B; Massip P; Izopet J
    AIDS; 2010 Sep; 24(15):2305-12. PubMed ID: 20808203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1.
    Grivel JC; Elliott J; Lisco A; Biancotto A; Condack C; Shattock RJ; McGowan I; Margolis L; Anton P
    AIDS; 2007 Jun; 21(10):1263-72. PubMed ID: 17545702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ligand-based and receptor-based virtual screening of HIV entry inhibitors for the CXCR4 and CCR5 receptors using 3D ligand shape matching and ligand-receptor docking.
    Pérez-Nueno VI; Ritchie DW; Rabal O; Pascual R; Borrell JI; Teixidó J
    J Chem Inf Model; 2008 Mar; 48(3):509-33. PubMed ID: 18298095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function studies of the HIV-1 coreceptors.
    Berson JF; Doms RW
    Semin Immunol; 1998 Jun; 10(3):237-48. PubMed ID: 9653050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In a human lymphomyeloid progenitor cell line (KG-1) HIV-1 gp120 binds to chemokine-receptors CXC-R4 and CCR5, only in the presence of CD4.
    Re MC; Vignoli M; Furlini G; Ramazzotti E; Maldini C; La Placa M
    New Microbiol; 1999 Oct; 22(4):365-8. PubMed ID: 10555208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 coreceptor selectivity: structural analogy between HIV-1 V3 regions and chemokine beta-hairpins is not the explanation.
    Scheib H; Sperisen P; Hartley O
    Structure; 2006 Apr; 14(4):645-7; discussion 649-51. PubMed ID: 16615905
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppression of multiclade R5 and X4 human immunodeficiency virus type-1 infections by a coreceptor-based anti-HIV strategy.
    Nakayama D; Misumi S; Mukai R; Tachibana K; Umeda M; Shibata H; Takamune N; Shoji S
    J Biochem; 2005 Nov; 138(5):571-82. PubMed ID: 16272569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new insight into the role of "old" chemotactic peptide receptors FPR and FPRL1: down-regulation of chemokine receptors CCR5 and CXCR4.
    Le Y; Shen W; Li B; Gong W; Dunlop NM; Wang JM
    Forum (Genova); 1999; 9(4):299-314. PubMed ID: 10611407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.